Promotional Information

Presents an integrated approach to the ethanol and butanol production processes from agricultural residues and bioenergy crops, and discusses improvements through research, consolidation, and integration of the processes

Table of Contents

PART I CELLULOSIC BIOMASS PROCESSING & BIOREFINERY ROAD MAP

CHAPTER 1 An Overview of Existing Individual Unit Operations

CHAPTER 2 Biomass for Biorefining: Resources, Allocation, Utilization, and Policies

CHAPTER 3 Biorefinery Roadmaps

CHAPTER 4 Integration of (Hemi)-Cellulosic Biofuels Technologies with Chemical Pulp Production

CHAPTER 5 Integrated Processes for Product Recovery

PART II CELLULOSIC ETHANOL

CHAPTER 6 Development of Growth-Arrested Bioprocesses with Corynebacterium glutamicum for Cellulosic Ethanol Production from Complex Sugar Mixtures

CHAPTER 7 Consolidated Bioprocessing for Ethanol Production

CHAPTER 8 Integration of Ethanol Fermentation with Second Generation Biofuels Technologies

PART III CELLULOSIC BUTANOL

CHAPTER 9 Mixed Sugar Fermentation by Clostridia and Metabolic Engineering for Butanol Production

CHAPTER 10 Integrated Bioprocessing and Simultaneous Product Recovery for Butanol Production

CHAPTER 11 Integrated Production of Butanol from Glycerol

PART IV PROCESS ECONOMICS & FARM-BASED BIOREFINERY

CHAPTER 12 Process Economics of Renewable Biorefineries: Butanol and Ethanol Production in Integrated Bioprocesses from Lignocellulosics and Other Industrial By-Products

CHAPTER 13 Integrated Farm-Based Biorefinery

About the Author

Research Chemical/Biochemical Engineer, United States Department of Agriculture (USDA), Agricultural Research Service (ARS), National Center for Agricultural Utilization Research (NCAUR), Peoria, IL, USA.
PhD (Chemical/Biological Engineering), PhD (Fermentation Technology)
Fellow in American Institute of Chemical Engineers (AIChE), Society for Industrial Microbiology & Biotechnology (SIMB), and American Institute of Chemists (AIC).
Co-Editor, Stem cells in Regenerative Medicine (Wiley, 2015) Michigan State University, MI USA University of Illinois at Urbana-Champaign, Institut Pasteur Paris, and University of Lille Flanders-Artois• Sloan Fellow from London Business School and a microbiologist by training (University of Illinois at Urbana-Champaign, Institut Pasteur Paris, and University of Lille Flandres-Artois). • Consulting, Partnering & Fund Raising, Founder, Managing Director, NxR Biotechnologies, Switzerland.• Dr. Vertès is a strategy and business development consultant for cell therapeutic biotech companies, and works to enable seed funding in the field. Focusing on technology deployment and innovation commercialization, he has contributed to both industrial and pharmaceutical biotechnology, in different functions including research, manufacturing, contract research, and strategic alliances in pharmaceuticals (Lilly, Pfizer, Roche). • Championed radical innovation for bringing to patients disease-modifying, paradigm-changing therapeutics such as siRNA, and led in a scientific and business manner Roche’s global cell therapeutics strategy and implementation team resulting in Roche’s entry in 2010 in the field of regenerative medicine.• Member, Industry Committee-Europe, Tissue Engineering and Regenerative Medicine International Society• Co-Editor, Stem Cells in Regenerative Medicine: Science, Regulation and Business Strategies (Wiley, 2015).

Reviews

"...an excellent book on the most urgent and important problems facing mankind today: sustainability in this era of shortage, environmental degradation, and climate change." --Biz India